The JANUS of chronic inflammatory and autoimmune diseases onset during COVID-19 – A systematic review of the literature

Journal of Autoimmunity - Tập 117 - Trang 102592 - 2021
Lucia Novelli1, Francesca Motta1,2, Maria De Santis1, Aftab A. Ansari3, M. Eric Gershwin3, Carlo Selmi1,2
1Division of Rheumatology and Clinical Immunology, Humanitas Clinical and Research Center- IRCCS, Rozzano, MI, Italy
2Humanitas University, Department of Biomedical Sciences, Pieve Emanuele (MI), Italy
3Division of Rheumatology, Department of Medicine, Allergy and Clinical Immunology, University of California at Davis, Davis, CA, USA

Tài liệu tham khảo

Gates, 2020, Responding to covid-19 — a once-in-a-century pandemic?, N. Engl. J. Med., 382, 1677, 10.1056/NEJMp2003762

Huang, 2020, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet, 395, 497, 10.1016/S0140-6736(20)30183-5

Yazdanpanah, 2020, The immune system and COVID-19: friend or foe?, Life Sci., 256, 10.1016/j.lfs.2020.117900

Vabret, 2020, Immunology of COVID-19: current state of the science, Immunity, 52, 910, 10.1016/j.immuni.2020.05.002

Mehta, 2020, COVID-19: consider cytokine storm syndromes and immunosuppression, Lancet, 395, 1033, 10.1016/S0140-6736(20)30628-0

Ceribelli, 2020, Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy, J. Autoimmun., 109, 10.1016/j.jaut.2020.102442

Rodríguez, 2020, Autoinflammatory and autoimmune conditions at the crossroad of COVID-19, J. Autoimmun., 114, 10.1016/j.jaut.2020.102506

Caso, 2020, Could Sars-coronavirus-2 trigger autoimmune and/or autoinflammatory mechanisms in genetically predisposed subjects?, Autoimmun. Rev., 19, 10.1016/j.autrev.2020.102524

Joo, 2019, Respiratory viral infections and the risk of rheumatoid arthritis, Arthritis Res. Ther., 21, 10.1186/s13075-019-1977-9

Moher, 2010, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement, Int. J. Surg., 8, 336, 10.1016/j.ijsu.2010.02.007

Liebman, 2017, 101, 351

Lopez, 2020, Simultaneous onset of COVID-19 and autoimmune haemolytic anaemia, Br. J. Haematol., 190, 31, 10.1111/bjh.16786

Zagorski, 2020, Cold agglutinin autoimmune haemolytic anaemia associated with novel coronavirus (COVID-19), Br. J. Haematol., 10.1111/bjh.16892

Wahlster, 2020, COVID-19 presenting with autoimmune hemolytic anemia in the setting of underlying immune dysregulation, Pediatr. Blood Canc., 67, 10.1002/pbc.28382

Angileri, 2020, Is molecular mimicry the culprit in the autoimmune haemolytic anaemia affecting patients with COVID-19?, Br. J. Haematol., 190, e92, 10.1111/bjh.16883

Li, 2020, Evans syndrome in a patient with COVID-19, Br. J. Haematol., 190, e59, 10.1111/bjh.16846

Vadlamudi, 2020, Evans syndrome associated with pregnancy and COVID-19 infection, Case Rep Obstet Gynecol, 2020

Lazarian, 2020, Autoimmune haemolytic anaemia associated with COVID-19 infection, Br. J. Haematol., 190, 29, 10.1111/bjh.16794

Zhou, 2020, The proportion of patients with thrombocytopenia in three human-susceptible coronavirus infections: a systematic review and meta-analysis, Br. J. Haematol., 189, 438, 10.1111/bjh.16655

Yang, 2005, Thrombocytopenia in patients with severe acute respiratory syndrome (review), Hematology, 10, 101, 10.1080/10245330400026170

Magdi, 2019, Severe immune thrombocytopenia complicated by intracerebral haemorrhage associated with coronavirus infection: a case report and literature review, Eur J Case Rep Intern Med, 6

Patel, 2020, Severe pediatric COVID-19 presenting with respiratory failure and severe thrombocytopenia, Pediatrics, 146, 10.1542/peds.2020-1437

Tsao, 2020, Immune thrombocytopenia (ITP) in a pediatric patient positive for SARS-CoV-2, Pediatrics, 146, 10.1542/peds.2020-1419

Soares, 2020, Outcome of SARS-CoV-2 and immune thrombocytopenia in a pediatric patient, Hematol Transfus Cell Ther, 10.1016/j.htct.2020.09.145

Rosenzweig, 2020, SARS-CoV-2 infection in two pediatric patients with immune cytopenias: a single institution experience during the pandemic, Pediatr. Blood Canc., 67, 10.1002/pbc.28503

Yang, 2020, Thrombocytopenia and its association with mortality in patients with COVID-19, J. Thromb. Haemostasis, 18, 1469, 10.1111/jth.14848

Lippi, 2020, Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis, Clin. Chim. Acta, 506, 145, 10.1016/j.cca.2020.03.022

Hu, 2020, Severe exacerbation of immune thrombocytopenia and COVID-19: the favorable response to corticosteroid-based therapy-a case report, Ann. Hematol., 1

Merli, 2020, Recurrence of immune thrombocytopenia at the time of SARS-CoV-2 infection, Ann. Hematol., 99, 1951, 10.1007/s00277-020-04130-2

Nesr, 2020, Immune thrombocytopenia flare with mild COVID-19 infection in pregnancy: a case report, Br. J. Haematol., 190, e146, 10.1111/bjh.16928

Tang, 2020, Immune thrombocytopenia due to COVID-19 during pregnancy, Am. J. Hematol., 95, E191, 10.1002/ajh.25877

Bomhof, 2020, COVID-19-associated immune thrombocytopenia, Br. J. Haematol., 190, e61, 10.1111/bjh.16850

Ahmed, 2020, Thrombocytopenia as an initial manifestation of COVID-19; case series and literature review, Br. J. Haematol., 189, 1057, 10.1111/bjh.16769

Albiol, 2020, Autoimmune thrombotic thrombocytopenic purpura (TTP) associated with COVID-19, Ann. Hematol., 99, 1673, 10.1007/s00277-020-04097-0

Chen, 2020, Delayed-phase thrombocytopenia in patients with coronavirus disease 2019 (COVID-19), Br. J. Haematol., 190, 179, 10.1111/bjh.16885

Russell, 2020, Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury, Lancet, 395, 473, 10.1016/S0140-6736(20)30317-2

Lodigiani, 2020, Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy, Thromb. Res., 191, 9, 10.1016/j.thromres.2020.04.024

Klok, 2020, Incidence of thrombotic complications in critically ill ICU patients with COVID-19, Thromb. Res., 191, 145, 10.1016/j.thromres.2020.04.013

Selmi, 2020, Anti-phospholipid antibody prevalence and association with subclinical atherosclerosis and atherothrombosis in the general population, Int. J. Cardiol., 300, 209, 10.1016/j.ijcard.2019.10.042

Manoussakis, 1987, High prevalence of anti-cardiolipin and other autoantibodies in a healthy elderly population, Clin. Exp. Immunol., 69, 557

Abdel-Wahab, 2016, Systematic review of case reports of antiphospholipid syndrome following infection, Lupus, 25, 1520, 10.1177/0961203316640912

Abdel-Wahab, 2017, Risk of developing antiphospholipid antibodies following viral infection: a systematic review and meta-analysis, Lupus, 27, 572, 10.1177/0961203317731532

Harzallah, 2020, Lupus anticoagulant is frequent in patients with Covid-19, J. Thromb. Haemostasis, 18, 2064, 10.1111/jth.14867

Xiao, 2020, Brief report: anti-phospholipid antibodies in critically ill patients with coronavirus disease 2019 (COVID-19), Arthritis Rheum.

Galeano-Valle, 2020, Antiphospholipid antibodies are not elevated in patients with severe COVID-19 pneumonia and venous thromboembolism, Thromb. Res., 192, 113, 10.1016/j.thromres.2020.05.017

Pineton de Chambrun, 2020, High frequency of antiphospholipid antibodies in critically ill COVID-19 patients: a link with hypercoagulability?, J. Intern. Med.

Connell, 2020, Coagulopathy of COVID-19 and antiphospholipid antibodies, J. Thromb. Haemostasis, 10.1111/jth.14893

Tang, 2020, Response to "Lupus anticoagulant is frequent in patients with Covid-19" (JTH-2020-00483), J. Thromb. Haemostasis, 18, 2065, 10.1111/jth.14890

Ludvigsson, 2020, Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults, Acta Paediatr., 109, 1088, 10.1111/apa.15270

Dong, 2020, Epidemiology of COVID-19 among children in China, Pediatrics, 145, 10.1542/peds.2020-0702

Kanegaye, 2009, Recognition of a Kawasaki disease shock syndrome, Pediatrics, 123, e783, 10.1542/peds.2008-1871

Wang, 2015, Macrophage activation syndrome in Kawasaki Disease: more common than we thought?, Semin. Arthritis Rheum., 44, 405, 10.1016/j.semarthrit.2014.07.007

Rowley, 2008, RNA-containing cytoplasmic inclusion bodies in ciliated bronchial epithelium months to years after acute Kawasaki disease, PloS One, 3, 10.1371/journal.pone.0001582

Rowley, 2011, Ultrastructural, immunofluorescence, and RNA evidence support the hypothesis of a "new" virus associated with Kawasaki disease, J. Infect. Dis., 203, 1021, 10.1093/infdis/jiq136

McCrindle Brian, 2017, Diagnosis, treatment, and long-term management of kawasaki disease: a scientific statement for Health professionals from the American Heart association, Circulation, 135, e927

Jiang, 2020, COVID-19 and multisystem inflammatory syndrome in children and adolescents, Lancet Infect. Dis., 20, e276, 10.1016/S1473-3099(20)30651-4

Verdoni, 2020, An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study, Lancet, 395, 1771, 10.1016/S0140-6736(20)31103-X

Toubiana, 2020, Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study, BMJ (Clinical research ed), 369, m2094

Li, 2019, Kawasaki disease shock syndrome: clinical characteristics and possible use of IL-6, IL-10 and IFN-γ as biomarkers for early recognition, Pediatr Rheumatol Online J, 17, 10.1186/s12969-018-0303-4

Pouletty, 2020, Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort, Ann. Rheum. Dis., 79, 999, 10.1136/annrheumdis-2020-217960

Miller, 2020, Gastrointestinal symptoms as a major presentation component of a novel multisystem inflammatory syndrome in children (MIS-C) that is related to COVID-19: a single center experience of 44 cases, Gastroenterology, 159, 1571, 10.1053/j.gastro.2020.05.079

Whittaker, 2020, Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2, J. Am. Med. Assoc., 324, 259, 10.1001/jama.2020.10369

Riphagen, 2020, Hyperinflammatory shock in children during COVID-19 pandemic, Lancet, 395, 1607, 10.1016/S0140-6736(20)31094-1

Kaushik, 2020, Multisystem inflammatory syndrome in children associated with severe acute respiratory syndrome coronavirus 2 infection: a multi-institutional study from New York city, J. Pediatr., S0022–3476

Hameed, 2020, Spectrum of imaging findings on chest radiographs, US, CT, and MRI images in multisystem inflammatory syndrome in children (MIS-C) associated with COVID-19, Radiology, 202543

Riollano-Cruz, 2020, Multisystem inflammatory syndrome in children (mis-C) related to COVID-19: a New York city experience, J. Med. Virol.

Feldstein, 2020, Multisystem inflammatory syndrome in U.S. Children and adolescents, N. Engl. J. Med., 383, 334, 10.1056/NEJMoa2021680

Kaushik, 2020, ECMO support in SARS-CoV2 multisystem inflammatory syndrome in children in a child, Perfusion, 10.1177/0267659120954386

López-González, 2020, Case series of acute arthritis during COVID-19 admission, Ann. Rheum. Dis., 10.1136/annrheumdis-2020-217914

Alivernini, 2020, Comparative analysis of synovial inflammation after SARS-CoV-2 infection, Ann. Rheum. Dis., 10.1136/annrheumdis-2020-218315

Yokogawa, 2020, Case of acute arthritis following SARS-CoV-2 infection, Ann. Rheum. Dis., 10.1136/annrheumdis-2020-218281

Saricaoglu, 2020, The first reactive arthritis case associated with COVID-19, J. Med. Virol.

Danssaert, 2020, Reactive arthritis in a 37-year-old female with SARS-CoV2 infection, Cureus, 12

Ono, 2020, Reactive arthritis after COVID-19 infection, RMD Open, 6, 10.1136/rmdopen-2020-001350

Gisondi, 2020, Cutaneous manifestations of SARS-CoV-2 infection: a clinical update, J. Eur. Acad. Dermatol. Venereol., 10.1111/jdv.16774

Criado, 2020, Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms, Inflamm. Res., 69, 745, 10.1007/s00011-020-01370-w

Galván Casas, 2020, Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases, Br. J. Dermatol., 183, 71, 10.1111/bjd.19163

Qin, 2020, Dysregulation of immune response in patients with COVID-19 in Wuhan, China, Clin. Infect. Dis., ciaa248

Desforges, 2019, Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system?, Viruses, 12, 14, 10.3390/v12010014

De Sanctis, 2020, Guillain-Barre syndrome associated with SARS-CoV-2 infection. A systematic review, Eur. J. Neurol., 27, 2361, 10.1111/ene.14462

Smatti, 2019, Viruses and autoimmunity: a review on the potential interaction and molecular mechanisms, Viruses, 11, 762, 10.3390/v11080762

Gough, 2007, The HLA region and autoimmune disease: associations and mechanisms of action, Curr. Genom., 8, 453, 10.2174/138920207783591690

Novelli, 2020

Cruz-Tapias, 2013, HLA association with autoimmune diseases

Santonja, 2020, COVID-19 chilblain-like lesion: immunohistochemical demonstration of SARS-CoV-2 spike protein in blood vessel endothelium and sweat gland epithelium in a polymerase chain reaction-negative patient, Br. J. Dermatol., 10.1111/bjd.19338

Triggianese, 2020, Immune checkpoint inhibitors-induced autoimmunity: the impact of gender, Autoimmun. Rev., 19, 102590, 10.1016/j.autrev.2020.102590

Jin, 2020, Gender differences in patients with COVID-19: focus on severity and mortality, Front Publ. Health, 8, 10.3389/fpubh.2020.00152

Group, 2020, Dexamethasone in hospitalized patients with covid-19 - preliminary report, N. Engl. J. Med.

Anaya, 2010, The autoimmune tautology, Arthritis Res. Ther., 12, 147, 10.1186/ar3175

Haberman, 2020, Covid-19 in immune-mediated inflammatory diseases - case series from New York, N. Engl. J. Med., 383, 85, 10.1056/NEJMc2009567

Gianfrancesco, 2020, Rheumatic disease and COVID-19: initial data from the COVID-19 Global Rheumatology Alliance provider registries, The Lancet Rheumatol., 2, e250, 10.1016/S2665-9913(20)30095-3

Kastritis, 2020, Systemic autoimmune diseases, anti-rheumatic therapies, COVID-19 infection risk and patient outcomes, Rheumatol. Int., 40, 1353, 10.1007/s00296-020-04629-x

Favalli, 2020, Incidence and clinical course of COVID-19 in patients with connective tissue diseases: a descriptive observational analysis, J. Rheumatol., 47, 1296, 10.3899/jrheum.200507

Quartuccio, 2020, Prevalence of COVID-19 among patients with chronic inflammatory rheumatic diseases treated with biologic agents or small molecules: a population-based study in the first two months of COVID-19 outbreak in Italy, Joint Bone Spine, 87, 439, 10.1016/j.jbspin.2020.05.003

Michelena, 2020, Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs, Semin. Arthritis Rheum., 50, 564, 10.1016/j.semarthrit.2020.05.001

Scirè, 2020, COVID-19 in rheumatic diseases in Italy: first results from the Italian registry of the Italian Society for Rheumatology (CONTROL-19), Clin. Exp. Rheumatol., 38, 748

Capes, 2020, COVID-19 infection associated with autoimmune hemolytic anemia, Ann. Hematol., 99, 1679, 10.1007/s00277-020-04137-9

Huscenot, 2020, SARS-CoV-2-associated cold agglutinin disease: a report of two cases, Ann. Hematol., 99, 1943, 10.1007/s00277-020-04129-9

Hindilerden, 2020, Severe autoimmune hemolytic anemia in COVID-19 i?nfection, safely treated with steroids, Mediterr J Hematol Infect Dis, 12, 10.4084/mjhid.2020.053

Patil, 2020, Cold agglutinin disease and autoimmune hemolytic anemia with pulmonary embolism as a presentation of COVID-19 infection, Hematol Oncol Stem Cell Ther, S1658–3876

Maslov, 2020, COVID-19 and cold agglutinin hemolytic anemia, TH Open, 4, e175, 10.1055/s-0040-1715791

Vega Hernández, 2020, Autoimmune hemolytic anemia in a pediatric patient with severe acute respiratory syndrome coronavirus 2 infection, Pediatr. Infect. Dis. J., 39, 10.1097/INF.0000000000002809

Moonla, 2020, Cold agglutinin disease following SARS-CoV-2 and Mycoplasma pneumoniae co-infections, Clin Case Rep, 10.1002/ccr3.3152

Jensen, 2020, Cold agglutinin syndrome as a complication of Covid-19 in two cases, Clin. Infect. Prac., 7–8, 100041, 10.1016/j.clinpr.2020.100041

Zulfiqar, 2020, Immune thrombocytopenic purpura in a patient with covid-19, N. Engl. J. Med., 382, 10.1056/NEJMc2010472

Yang, 2020, A rare case of immune thrombocytopenic purpura, secondary to COVID-19, J. Med. Virol., 10.1002/jmv.26051

Chen, 2020, Sudden severe thrombocytopenia in a patient in the recovery stage of COVID-19, Lancet Haematol., 7, e624, 10.1016/S2352-3026(20)30175-7

Murt, 2020, COVID-19 presenting with immune thrombocytopenia: a case report and review of the literature, J. Med. Virol.

Humbert, 2020, COVID-19 as a cause of immune thrombocytopenia, Med. Maladies Infect., 50, 459, 10.1016/j.medmal.2020.05.003

Lorenzo-Villalba, 2020, Thrombocytopenia in the course of COVID-19 infection, Eur J Case Rep Intern Med, 7

Revuz, 2020, Immune thrombocytopenic purpura in patients with COVID-19, Eur J Case Rep Intern Med, 7

Lévesque, 2020, Severe immune thrombocytopenic purpura in critical COVID-19, Int. J. Hematol., 112, 746, 10.1007/s12185-020-02931-9

Artru, 2020, Acute immune thrombocytopaenic purpura in a patient with COVID-19 and decompensated cirrhosis, BMJ Case Rep., 13, 10.1136/bcr-2020-236815

Hayden, 2020, Severe refractory thrombocytopenia in a woman positive for coronavirus disease 2019 with lupus and antiphospholipid syndrome, Lupus, 29, 1472, 10.1177/0961203320940389

Bennett, 2020, Immune thrombocytopenia purpura secondary to COVID-19, Cureus, 12

Hindilerden, 2020, Immune thrombocytopenia in a very elderly patient with covid-19, Front. Med., 7, 10.3389/fmed.2020.00404

Deruelle, 2020, Immune thrombocytopenia in a patient with COVID-19, Int. J. Hematol., 112, 883, 10.1007/s12185-020-02943-5

Mahévas, 2020, Clinical characteristics, management and outcome of COVID-19-associated immune thrombocytopenia: a French multicentre series, Br. J. Haematol., 10.1111/bjh.17024

Kondo, 2020, Exacerbation of immune thrombocytopaenia triggered by COVID-19 in patients with systemic lupus erythematosus, Ann. Rheum. Dis., 10.1136/annrheumdis-2020-218157

Martincic, 2020, Severe immune thrombocytopenia in a critically ill COVID-19 patient, Int. J. Infect. Dis., 99, 269, 10.1016/j.ijid.2020.08.002

Malik, 2020, Paying in blood: a case of thrombocytopenia in covid-19, Cureus, 12

Pascolini, 2020, Coronavirus disease associated immune thrombocytopenia: causation or correlation?, J. Microbiol. Immunol. Infect., 10.1016/j.jmii.2020.08.006

Patel, 2020, Severe thrombocytopaenia secondary to COVID-19, BMJ Case Rep., 13, 10.1136/bcr-2020-237645

Soares, 2020, Outcome of SARS-CoV-2 and immune thrombocytopenia in a pediatric patient, Hematol. Trans. Cell Ther., 10.1016/j.htct.2020.09.145

Kewan, 2020, COVID-19 patient with immune thrombocytopenic purpura, Int J Lab Hematol, 10.1111/ijlh.13303

Pedro Lobos, 2020, Immune thrombocytopenic purpura associated with coronavirus 19 infection IN an asymptomatic young healthy patient, JAAD Case Rep., 6, 1129, 10.1016/j.jdcr.2020.08.037

Levraut, 2020, Immune thrombocytopenic purpura after COVID-19 infection, Int J Lab Hematol

Zhang, 2020, Coagulopathy and antiphospholipid antibodies in patients with covid-19, N. Engl. J. Med., 382, 10.1056/NEJMc2007575

Hossri, 2020, Clinically significant anticardiolipin antibodies associated with COVID-19, J. Crit. Care, 59, 32, 10.1016/j.jcrc.2020.05.017

Valencia Manrique, 2020, Anticardiolipin antibodies and COVID-19-A case report from America, J. Med. Virol.

Zayet, 2020, Acute cerebral stroke with multiple infarctions and COVID-19, France, 2020, Emerg. Infect. Dis. J., 26

Sung, 2020, Coronavirus disease 2019 (COVID-19) infection associated with antiphospholipid antibodies and four-extremity deep vein thrombosis in a previously healthy female, Cureus, 12

Escher, 2020, Severe COVID-19 infection associated with endothelial activation, Thromb. Res., 190, 10.1016/j.thromres.2020.04.014

Helms, 2020, High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study, Intensive Care Med., 46, 1089, 10.1007/s00134-020-06062-x

Bowles, 2020, Lupus anticoagulant and abnormal coagulation tests in patients with covid-19, N. Engl. J. Med., 383, 288, 10.1056/NEJMc2013656

Previtali, 2020, The pathogenesis of thromboembolic disease in covid-19 patients: could be a catastrophic antiphospholipid syndrome?, Thromb. Res., 194, 192, 10.1016/j.thromres.2020.06.042

Gatto, 2020, Frequency and clinical correlates of antiphospholipid antibodies arising in patients with SARS-CoV-2 infection: findings from a multicentre study on 122 cases, Clin. Exp. Rheumatol., 38, 754

Devreese, 2020, Antiphospholipid antibodies in patients with COVID-19: a relevant observation?, J. Thromb. Haemostasis, 10.1111/jth.14994

Siguret, 2020, Are antiphospholipid antibodies associated with thrombotic complications in critically ill COVID-19 patients?, Thromb. Res., 195, 74, 10.1016/j.thromres.2020.07.016

Fan, 2020, Neurological manifestations in critically ill patients with COVID-19: a retrospective study, Front. Neurol., 11, 10.3389/fneur.2020.00806

Shoskes, 2020, Cerebral microhemorrhage and purpuric rash in COVID-19: the case for a secondary microangiopathy, J. Stroke Cerebrovasc. Dis., 29, 10.1016/j.jstrokecerebrovasdis.2020.105111

Rothstein, 2020, Acute cerebrovascular events in hospitalized COVID-19 patients, Stroke, 51, e219, 10.1161/STROKEAHA.120.030995

Reyes Gil, 2020, Assessment of lupus anticoagulant positivity in patients with coronavirus disease 2019 (COVID-19), JAMA network open, 3, 10.1001/jamanetworkopen.2020.17539

Amezcua-Guerra, 2020, Presence of antiphospholipid antibodies in COVID-19: case series study, Ann. Rheum. Dis., 10.1136/annrheumdis-2020-218100

Yarlagadda, 2020, A 31-year-old man with COVID-19-associated empyema and lupus anticoagulant, Am J Case Rep, 21, 10.12659/AJCR.926623

Gutiérrez López de Ocáriz, 2020, Thrombosis and antiphospholipid antibodies in patients with SARS-COV-2 infection (COVID-19), Int J Lab Hematol, 10.1111/ijlh.13320

Gemcioglu, 2020, Acute ischemic stroke in a lupus anticoagulant-positive woman with COVID-19, J. Clin. Rheumatol., 26, 236, 10.1097/RHU.0000000000001565

Tvito, 2020, Lupus anticoagulant in patients with COVID-19, Int J Lab Hematol

Maria, 2020, Flare of antiphospholipid syndrome in the course of COVID-19, TH Open, 4, e207, 10.1055/s-0040-1716735

Ferrari E, Sartre B, Squara F, Contenti J, Occelli C, Lemoel F et al. High prevalence of acquired thrombophilia without prognosis value in Covid‐19 patients. J Am Heart Assoc;0:e017773.

Pascolini, 2020, COVID-19 and immunological dysregulation: can autoantibodies be useful?, Clin Transl Sci, 29, 12908

Hasan Ali, 2020, Severe COVID-19 is associated with elevated serum IgA and antiphospholipid IgA-antibodies, Clin. Infect. Dis., ciaa1496, 10.1093/cid/ciaa1496

Zhang, 2020, Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients, J. Thromb. Thrombolysis, 50, 580, 10.1007/s11239-020-02182-9

Yasri, 2020, COVID-19, antiphospholipid syndrome and thrombosis, Clin. Appl. Thromb. Hemost., 26, 10.1177/1076029620931927

Bertin, 2020, Anticardiolipin IgG autoantibody level is an independent risk factor for COVID-19 severity, Arthritis Rheum., 10.1002/art.41409

Renaud-Picard, 2020, Bilateral acute cardioembolic limb ischemia after coronavirus disease 2019 pneumonia in a lung transplant recipient: a case report, Transplant. Proc., S0041–1345

Zarza, 2020, Evans syndrome associated with antiphospholipid antibodies in a patient with SARS-COV-2 infection, Hematol Transfus Cell Ther, 10.1016/j.htct.2020.08.003

Mantovani Cardoso, 2020, Concomitant new diagnosis of systemic lupus erythematosus and COVID-19 with possible antiphospholipid syndrome. Just a coincidence? A case report and review of intertwining pathophysiology, Clin. Rheumatol., 39, 2811, 10.1007/s10067-020-05310-1

Slimani, 2020, Systemic lupus erythematosus and varicella-like rash following COVID-19 in a previously healthy patient, J. Med. Virol.

Bonometti, 2020, The first case of systemic lupus erythematosus (SLE) triggered by COVID-19 infection, Eur. Rev. Med. Pharmacol. Sci., 24, 9695

El Aoud, 2020, SARS CoV-2 presenting as lupus erythematosus-like syndrome, Disaster Med. Public Health Prep., 1, 10.1017/dmp.2020.358

Raghavan, 2020, A case of systemic lupus erythematosus flare triggered by severe coronavirus disease 2019, J. Clin. Rheumatol., 26, 234, 10.1097/RHU.0000000000001531

Ratner, 2020, COVID-19 coagulopathy in a patient with systemic lupus erythematosus and antiphospholipid antibodies, J. Clin. Rheumatol.

Uppal, 2020, De novo ANCA-associated vasculitis with glomerulonephritis in COVID-19, Kidney Int Rep, 10.1016/j.ekir.2020.08.012

Hussein, 2020, Anti-neutrophilic cytoplasmic antibody (ANCA) vasculitis presented as pulmonary hemorrhage in a positive COVID-19 patient: a case report, Cureus, 12

Jones, 2020, COVID-19 and kawasaki disease: novel virus and novel case, Hosp. Pediatr., 10, 537, 10.1542/hpeds.2020-0123

Rivera-Figueroa, 2020, Incomplete kawasaki disease in a child with covid-19, Indian Pediatr., 57, 680, 10.1007/s13312-020-1900-0

Balasubramanian, 2020, Hyper-inflammatory syndrome in a child with COVID-19 treated successfully with intravenous immunoglobulin and tocilizumab, Indian Pediatr., 57, 681, 10.1007/s13312-020-1901-z

Acharyya, 2020

Waltuch, 2020, Features of COVID-19 post-infectious cytokine release syndrome in children presenting to the emergency department, Am. J. Emerg. Med., 38, 2246.e3, 10.1016/j.ajem.2020.05.058

Cheung, 2020, Multisystem inflammatory syndrome related to COVID-19 in previously healthy children and adolescents in New York city, J. Am. Med. Assoc., 324, 294, 10.1001/jama.2020.10374

Belhadjer, 2020, Acute Heart failure in multisystem inflammatory syndrome in children in the context of global SARS-CoV-2 pandemic, Circulation, 142, 429, 10.1161/CIRCULATIONAHA.120.048360

Ng, 2020, COVID-19 multisystem inflammatory syndrome in three teenagers with confirmed SARS-CoV-2 infection, J. Med. Virol., 10.1002/jmv.26206

Dolinger, 2020, Pediatric crohn disease and multisystem inflammatory syndrome in children (MIS-C) and COVID-19 treated with infliximab, J. Pediatr. Gastroenterol. Nutr., 71, 153, 10.1097/MPG.0000000000002809

Licciardi, 2020, SARS-CoV-2–Induced kawasaki-like hyperinflammatory syndrome: a novel COVID phenotype in children, Pediatrics, 146, 10.1542/peds.2020-1711

Deza Leon, 2020, COVID-19-Associated pediatric multisystem inflammatory syndrome, J Pediatric Infect Dis Soc, 9, 407, 10.1093/jpids/piaa061

Labé, 2020, Erythema multiforme and Kawasaki disease associated with COVID-19 infection in children, J. Eur. Acad. Dermatol. Venereol., 10.1111/jdv.16666

Rauf, 2020, Multisystem inflammatory syndrome with features of atypical kawasaki disease during COVID-19 pandemic, Indian J. Pediatr., 87, 745, 10.1007/s12098-020-03357-1

Chiotos, 2020, Multisystem inflammatory syndrome in children during the coronavirus 2019 pandemic: a case series, J Pediatric Infect Dis Soc, 9, 393, 10.1093/jpids/piaa069

Grimaud, 2020, Acute myocarditis and multisystem inflammatory emerging disease following SARS-CoV-2 infection in critically ill children, Ann. Intensive Care, 10, 10.1186/s13613-020-00690-8

Yozgat, 2020, Dermatological manifestation of pediatrics multisystem inflammatory syndrome associated with COVID-19 in a 3-year-old girl, Dermatol. Ther., 33, 10.1111/dth.13770

Blondiaux, 2020, Cardiac MRI of children with multisystem inflammatory syndrome (MIS-C) associated with COVID-19, Case Series. Radiol., 297, E283

Belot, 2020, SARS-CoV-2-related paediatric inflammatory multisystem syndrome, an epidemiological study, France, 1 March to 17 May 2020, Euro Surveill., 25, 2001010, 10.2807/1560-7917.ES.2020.25.22.2001010

Ramcharan, 2020, Paediatric inflammatory multisystem syndrome: temporally associated with SARS-CoV-2 (PIMS-TS): cardiac features, management and short-term outcomes at a UK tertiary paediatric hospital, Pediatr. Cardiol., 1

Greene, 2020, Toxic shock-like syndrome and COVID-19: a case report of multisystem inflammatory syndrome in children (MIS-C), Am. J. Emerg. Med., S0735–6757, 30492

Schnapp, 2020, Introductory histopathological findings may shed light on COVID-19 paediatric hyperinflammatory shock syndrome, J. Eur. Acad. Dermatol. Venereol., 10.1111/jdv.16749

Chiu, 2020, Kawasaki disease features and myocarditis in a patient with COVID-19, Pediatr. Cardiol., 1

Capone, 2020, Characteristics, cardiac involvement, and outcomes of multisystem inflammatory disease of childhood (MIS-C) associated with SARS-CoV-2 infection, J. Pediatr., S0022–3476

Dasgupta, 2020, A case of pediatric multisystem inflammatory syndrome temporally associated with COVID-19 in south Dakota, South Dakota Med. : J. South Dakota State Med. Assoc., 73, 246

Dufort, 2020, Multisystem inflammatory syndrome in children in New York state, N. Engl. J. Med., 383, 347, 10.1056/NEJMoa2021756

Alnashri, 2020, A challenging case of multisystem inflammatory syndrome in children related to coronavirus Disease-19 hospitalized under adult medical service, IDCases, 22, 10.1016/j.idcr.2020.e00957

Giannattasio, 2020, A child with a severe multisystem inflammatory syndrome following an asymptomatic COVID-19 infection: a novel management for a new disease?, J. Med. Virol.

Chérif, 2020, Coronavirus disease 2019-related Kawasaki-like disease in an adult: a case report, JAAD Case Rep., 6, 780, 10.1016/j.jdcr.2020.06.023

Sokolovsky, 2020, COVID-19 associated Kawasaki-like multisystem inflammatory disease in an adult, Am. J. Emerg. Med., S0735–6757, 30542

Ferrero, 2020, Patterns of myocardial involvement in children during COVID-19 pandemic: early experience from northern Italy, Ann. Pediatr. Cardiol., 13, 230, 10.4103/apc.APC_77_20

Ouldali, 2020, Emergence of Kawasaki disease related to SARS-CoV-2 infection in an epicentre of the French COVID-19 epidemic: a time-series analysis, Lancet Child Adolesc Health, 4, 662, 10.1016/S2352-4642(20)30175-9

Vari, 2020, Severe cardiac dysfunction in a patient with multisystem inflammatory syndrome in children associated with COVID-19: retrospective diagnosis of a puzzling presentation. A case report, Prog. Pediatr. Cardiol., 58, 101270, 10.1016/j.ppedcard.2020.101270

Cazzaniga, 2020, SARS-COV-2 infection and kawasaki disease: case report of a hitherto unrecognized association, Front Pediatr, 8, 10.3389/fped.2020.00398

Davies, 2020, Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: a multicentre observational study, The Lancet Child & Adolescent Health, 4, 669, 10.1016/S2352-4642(20)30215-7

Shaigany, 2020, An adult with Kawasaki-like multisystem inflammatory syndrome associated with COVID-19, Lancet, 396, e8, 10.1016/S0140-6736(20)31526-9

Vergnano, 2020, Severe refractory Kawasaki disease in seven infants in the COVID-19 era, The Lancet Rheumatol., 2, 10.1016/S2665-9913(20)30231-9

Cogan, 2020, Multisystem inflammatory syndrome with complete kawasaki disease features associated with SARS-CoV-2 infection in a young adult. A case report, Front. Med., 7, 10.3389/fmed.2020.00428

Lee, 2020, Distinct clinical and immunological features of SARS–CoV-2–induced multisystem inflammatory syndrome in children, J. Clin. Inves., 130

Khan, 2020, SARS-CoV-2 causes Kawasaki-like disease in children: cases reported in Pakistan, J. Med. Virol.

Bonnet, 2020, Endomyocardial biopsy findings in Kawasaki-like disease associated with SARS-CoV-2, Eur. Heart J., 10.1093/eurheartj/ehaa588

Moraleda, 2020, Multi-inflammatory syndrome in children related to SARS-CoV-2 in Spain, Clin. Infect. Dis., 10.1093/cid/ciaa1042

Regev, 2020, Pediatric inflammatory multisystem syndrome with central nervous system involvement and hypocomplementemia following SARS-COV-2 infection, Pediatr. Infect. Dis. J., 39, 10.1097/INF.0000000000002804

Raut, 2020, Incomplete kawasaki disease as presentation of COVID-19 infection in an infant: a case report, J. Trop. Pediatr., 10.1093/tropej/fmaa047

Mamishi, 2020, Novel coronavirus disease 2019 (COVID-19) outbreak in children in Iran: atypical CT manifestations and mortality risk of severe COVID-19 infection, J. Microbiol. Immunol. Infect., 30177

Theocharis, 2020, Multimodality cardiac evaluation in children and young adults with multisystem inflammation associated with COVID-19, Eur Heart J Cardiovasc Imaging, jeaa212, 10.1093/ehjci/jeaa212

Gupta, 2020, Multi-system inflammatory syndrome in a child mimicking kawasaki disease, J. Trop. Pediatr., 10.1093/tropej/fmaa060

Heidemann, 2020, Three cases of pediatric multisystem inflammatory syndrome associated with COVID-19 due to SARS-CoV-2, Am J Case Rep, 21, 10.12659/AJCR.925779

Godfred-Cato, 2020, COVID-19-Associated multisystem inflammatory syndrome in children - United States, march-July 2020, MMWR Morb. Mortal. Wkly. Rep., 69, 1074, 10.15585/mmwr.mm6932e2

Iio, 2020, Kawasaki disease or Kawasaki-like disease: influence of SARS-CoV-2 infections in Japan, Acta Paediatr.

Carter, 2020, Peripheral immunophenotypes in children with multisystem inflammatory syndrome associated with SARS-CoV-2 infection, Nat. Med., 26, 1701, 10.1038/s41591-020-1054-6

de Farias, 2020, Multisystem Inflammatory Syndrome Associated With Coronavirus Disease in Children: A Multi-centered Study in Belem, Para, Brazil, Pediatr. Infect. Dis., 39, e374, 10.1097/INF.0000000000002865

Lidder, 2020, An adult with COVID-19 kawasaki-like syndrome and ocular manifestations, Am J Ophthalmol Case Rep, 20

Lin, 2020, Cytotoxic lesion of the corpus callosum in an adolescent with multisystem inflammatory syndrome and SARS-CoV-2 infection, Am. J. Neuroradiol., 41, 2017, 10.3174/ajnr.A6755

Mamishi, 2020, Multisystem inflammatory syndrome associated with SARS-CoV-2 infection in 45 children: a first report from Iran, Epidemiol. Infect., 148, e196, 10.1017/S095026882000196X

Okarska-Napierała, 2020, Fever and diarrhea as the only symptoms of multisystem inflammatory syndrome in children (MIS-C), Gastroenterology, S0016–5085

Matsubara, 2020, Echocardiographic findings in pediatric multisystem inflammatory syndrome associated with COVID-19 in the United States, J. Am. Coll. Cardiol., S0735–1097

Gruber, 2020, Mapping systemic inflammation and antibody responses in multisystem inflammatory syndrome in children (MIS-C), Cell, 183, 928, 10.1016/j.cell.2020.09.034

Masih, 2020, Paediatric case of prolonged COVID-19 manifesting as PMIS-TS and atypical Kawasaki, BMJ Case Rep., 13, 10.1136/bcr-2020-237194

Pereira, 2020, Severe clinical spectrum with high mortality in pediatric patients with COVID-19 and multisystem inflammatory syndrome, Clinics, 75, 10.6061/clinics/2020/e2209

DeBiasi, 2020, Severe coronavirus disease-2019 in children and young adults in the Washington, DC, metropolitan region, J. Pediatr., 223, 199, 10.1016/j.jpeds.2020.05.007

Wolfler, 2020, Acute myocardial injury: a novel clinical pattern in children with COVID-19, Lancet Child Adolesc Health, 4, e26, 10.1016/S2352-4642(20)30168-1

Farias, 2020, Mello MLFMFd. multisystem inflammatory syndrome IN A child associated with coronavirus disease 19 IN the BRAZILIAN amazon: fatal outcome IN an infant, Rev Paul Pediatr, 38, 10.1590/1984-0462/2020/38/2020165

Schupper, 2020, Neurological manifestations of pediatric multi-system inflammatory syndrome potentially associated with COVID-19, Childs Nerv Syst, 36, 1579, 10.1007/s00381-020-04755-8

Rojahn, 2020, Multiorgan inflammatory syndrome associated with SARS-CoV-2 in a child, 140

Nguyen, 2020, Pediatric case of severe COVID-19 with shock and multisystem inflammation, Cureus, 12

Bahrami, 2020, Hyperinflammatory shock related to COVID-19 in a patient presenting with multisystem inflammatory syndrome in children: first case from Iran, J. Paediatr. Child Health, 10.1111/jpc.15048

Kest, 2020, Multisystem inflammatory syndrome in children (MIS-C) associated with 2019 novel coronavirus (SARS-CoV-2) infection, Case Rep Pediatr, 2020

Levin, 2020, Imaging findings in multisystem inflammatory syndrome in children (MIS-C) associated with COVID-19, Am. J. Roentgenol.

Diorio, 2020, Multisystem inflammatory syndrome in children and COVID-19 are distinct presentations of SARS–CoV-2, J. Clin. Inves., 130

Gaitonde, 2020, COVID-19-Related multisystem inflammatory syndrome in children affects left ventricular function and global strain compared with kawasaki disease, J. Am. Soc. Echocardiogr., 33, 1285, 10.1016/j.echo.2020.07.019

Jhaveri, 2020, Longitudinal echocardiographic assessment of coronary arteries and left ventricular function following multisystem inflammatory syndrome in children, J. Pediatr., S0022–3476, 30984

Jain, 2020, Multisystem inflammatory syndrome in children with COVID-19 in Mumbai, India, Indian Pediatr., 57, 1015, 10.1007/s13312-020-2026-0

Verkuil, 2020, Pseudotumor cerebri syndrome associated with MIS-C: a case report, Lancet, 396, 532, 10.1016/S0140-6736(20)31725-6

Webb, 2020, Multisystem inflammatory syndrome in children in South Africa, Lancet Child Adolesc Health, 4, 10.1016/S2352-4642(20)30272-8

Domico, 2020, High-grade Heart Block requiring transvenous pacing associated with multisystem inflammatory syndrome in children during the COVID-19 pandemic, HeartRhythm Case Rep, 10.1016/j.hrcr.2020.08.015

Swann, 2020, Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study, BMJ, 370, m3249, 10.1136/bmj.m3249

Torres, 2020, Multisystem inflammatory syndrome in children (MIS-C): report of the clinical and epidemiological characteristics of cases in Santiago de Chile during the SARS-CoV-2 pandemic, Int. J. Infect. Dis., 100, 75, 10.1016/j.ijid.2020.08.062

Lishman, 2020, Acute Appendicitis in Multisystem Inflammatory Syndrome in Children With COVID-19, Pediatr. Infect. Dis. J., 39, e472, 10.1097/INF.0000000000002900

Tam, 2020, Pediatric inflammatory multisystem syndrome temporally associated with COVID-19: a spectrum of diseases with many names, Can. Med. Assoc. J., 192, E1093, 10.1503/cmaj.201600

Jain, 2020, Multisystem inflammatory syndrome in children associated with COVID 19 treated with oral steroid, Indian J. Pediatr., 10.1007/s13312-020-2026-0

Biko, 2020, Imaging of children with COVID-19: experience from a tertiary children's hospital in the United States, Pediatr. Radiol., 1

Minocha, 2020, Cardiac findings in pediatric patients with multisystem inflammatory syndrome in children associated with COVID-19, Clin. Pediatr.

Kofman, 2020, A young adult with COVID-19 and multisystem inflammatory syndrome in children (MIS-C)-like illness: a case report, BMC Infect. Dis., 20, 10.1186/s12879-020-05439-z

Jonat, 2020, Multisystem Inflammatory Syndrome in Children Associated With Coronavirus Disease 2019 in a Children’s Hospital in New York City: Patient Characteristics and an Institutional Protocol for Evaluation, Management, and Follow-Up, Pediatr. Crit. Care Med., 10.1097/PCC.0000000000002598

Nelson, 2020, Multisystem inflammatory syndrome in children (mis-C) in an adolescent that developed coronary aneurysms: a case report and review of the literature, J. Emerg. Med., 59, 699, 10.1016/j.jemermed.2020.09.008

Klocperk, 2020, Case report: systemic inflammatory response and fast recovery in a pediatric patient with COVID-19, Front. Immunol., 11, 10.3389/fimmu.2020.01665

Lang, 2020, Defibrotide for the treatment of PIMS-TS in two pediatric patients, J Pediatric Infect Dis Soc, 9, 622, 10.1093/jpids/piaa117

Kim, 2020, Hospitalization rates and characteristics of children aged <18 Years hospitalized with laboratory-confirmed COVID-19 - COVID-NET, 14 states, march 1-July 25, 2020, MMWR Morb. Mortal. Wkly. Rep., 69, 1081, 10.15585/mmwr.mm6932e3

Consiglio, 2020, The immunology of multisystem inflammatory syndrome in children with COVID-19, Cell, S0092–8674

Cantor, 2020, Acute hepatitis is a prominent presentation of the multisystem inflammatory syndrome in children: a single-center report, Hepatology, n/a

Yonker, 2020, Pediatric SARS-CoV-2: clinical presentation, infectivity, and immune responses, J. Pediatr., S0022–3476, 31023

Harwood, 2020, Paediatric abdominal pain in the time of COVID-19: a new diagnostic dilemma, J. Surg. Case Rep., 2020, rjaa337, 10.1093/jscr/rjaa337

Stevens, 2020, COVID-19-Associated multisystem inflammatory syndrome in children presenting as acute pancreatitis, J. Pediatr. Gastroenterol. Nutr., 28

Sahn, 2020, Features of intestinal disease associated with COVID-related multisystem inflammatory syndrome in children, J. Pediatr. Gastroenterol. Nutr., 10.1097/MPG.0000000000002953

Kalner, 2020, Periorbital erythema as a presenting sign of covid-19, JAAD Case Rep., 10.1016/j.jdcr.2020.05.001

Colonna, 2020, Chilblain-like lesions in children following suspected COVID-19 infection, Pediatr. Dermatol., 37, 437, 10.1111/pde.14210

Magro, 2020, Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases, Transl. Res., 220, 1, 10.1016/j.trsl.2020.04.007

García-Legaz Martínez, 2020, Acute acral cutaneous manifestations during the COVID-19 pandemic: a single-centre experience, J. Eur. Acad. Dermatol. Venereol., 10.1111/jdv.16777

Verheyden, 2020, Relapsing symmetric livedo reticularis in a patient with COVID-19 infection, J. Eur. Acad. Dermatol. Venereol., 10.1111/jdv.16773

Hubiche, 2020, Negative SARS-CoV-2 PCR in patients with chilblain-like lesions, Lancet Infect. Dis., S1473–3099

Colmenero, 2020, SARS-CoV-2 endothelial infection causes COVID-19 chilblains: histopathological, immunohistochemical and ultrastructural study of seven paediatric cases, Br. J. Dermatol., 10.1111/bjd.19327

Negrini, 2020, An unusual case of bullous haemorrhagic vasculitis in a COVID-19 patient, J. Eur. Acad. Dermatol. Venereol., 10.1111/jdv.16760

Del Giudice, 2020, Catastrophic acute bilateral lower limbs necrosis associated with COVID-19 as a likely consequence of both vasculitis and coagulopathy, J. Eur. Acad. Dermatol. Venereol., 10.1111/jdv.16763

Larrondo, 2020, Papular-purpuric exanthem in a COVID-19 patient: clinical and dermoscopic description, J. Eur. Acad. Dermatol. Venereol., 10.1111/jdv.16732

Caputo, 2020, A generalized purpuric eruption with histopathologic features of leucocytoclastic vasculitis in a patient severely ill with COVID-19, J. Eur. Acad. Dermatol. Venereol., 10.1111/jdv.16737

Karaca, 2020, A unilateral purpuric rash in a patient with COVID-19 infection, Dermatol. Ther., 33, 10.1111/dth.13798

Rossi, 2020, Acute maculopapular eruption in Covid-19 patient: a case report, Dermatol. Ther., n/a

Rubio-Muniz, 2020, The broad spectrum of dermatological manifestations in COVID-19: clinical and histopathological features learned from a series of 34 cases, J. Eur. Acad. Dermatol. Venereol., 10.1111/jdv.16734

de Perosanz-Lobo, 2020, Urticarial vasculitis in COVID-19 infection: a vasculopathy-related symptom?, J. Eur. Acad. Dermatol. Venereol., 10.1111/jdv.16713

Wollina, 2020, Schamberg-like purpuric eruptions and tonsillitis in mild COVID-19, Dermatol. Ther., 33, 10.1111/dth.13766

Colonna, 2020, Outbreak of chilblain-like acral lesions in children in the metropolitan area of Milan, Italy, during the COVID-19 pandemic, J. Am. Acad. Dermatol., 83, 965, 10.1016/j.jaad.2020.06.019

Reymundo, 2020, Clinical and histological characterization of late appearance maculopapular eruptions in association with the coronavirus disease 2019. A case series of seven patients, J. Eur. Acad. Dermatol. Venereol., 10.1111/jdv.16707

Bosch-Amate, 2020, Retiform purpura as a dermatological sign of coronavirus disease 2019 (COVID-19) coagulopathy, J. Eur. Acad. Dermatol. Venereol., 10.1111/jdv.16689

Freeman, 2020, Pernio-like skin lesions associated with COVID-19: a case series of 318 patients from 8 countries, J. Am. Acad. Dermatol., 83, 486, 10.1016/j.jaad.2020.05.109

Balestri, 2020, Late onset of acral necrosis after SARS-CoV-2 infection resolution, J. Eur. Acad. Dermatol. Venereol., 10.1111/jdv.16668

Dominguez-Santas, 2020, Cutaneous small-vessel vasculitis associated with novel 2019 coronavirus SARS-CoV-2 infection (COVID-19), J. Eur. Acad. Dermatol. Venereol., 10.1111/jdv.16663

Docampo-Simón, 2020, Are chilblain-like acral skin lesions really indicative of COVID-19? A prospective study and literature review, J. Eur. Acad. Dermatol. Venereol., 10.1111/jdv.16665

Mayor-Ibarguren, 2020, Cutaneous small vessel vasculitis secondary to COVID-19 infection: a case report, J. Eur. Acad. Dermatol. Venereol., 10.1111/jdv.16670

García-Gil, 2020, Acral purpuric lesions (erythema multiforme type) associated with thrombotic vasculopathy in a child during the COVID-19 pandemic, J. Eur. Acad. Dermatol. Venereol., 10.1111/jdv.16644

de Medeiros, 2020, Follow-up of skin lesions during the evolution of COVID-19: a case report, Arch. Dermatol. Res., 1

Cepeda-Valdes, 2020, Cutaneous manifestations in COVID-19: familial cluster of urticarial rash, Clin. Exp. Dermatol., 10.1111/ced.14290

Cordoro, 2020, Clustered cases of acral perniosis: clinical features, histopathology, and relationship to COVID-19, Pediatr. Dermatol., 37, 419, 10.1111/pde.14227

Locatelli, 2020, Histologic features of long-lasting chilblain-like lesions in a paediatric COVID-19 patient, J. Eur. Acad. Dermatol. Venereol., 34, e365, 10.1111/jdv.16617

Sachdeva, 2020, Cutaneous manifestations of COVID-19: report of three cases and a review of literature, J. Dermatol. Sci., 98, 75, 10.1016/j.jdermsci.2020.04.011

de Masson, 2020, Chilblains is a common cutaneous finding during the COVID-19 pandemic: a retrospective nationwide study from France, J. Am. Acad. Dermatol., 83, 667, 10.1016/j.jaad.2020.04.161

Suarez-Valle, 2020, Acro-ischaemia in hospitalized COVID-19 patients, J. Eur. Acad. Dermatol. Venereol., 10.1111/jdv.16592

Kolivras, 2020, Coronavirus (COVID-19) infection-induced chilblains: a case report with histopathologic findings, JAAD Case Rep., 6, 489, 10.1016/j.jdcr.2020.04.011

Tosti, 2020, Skin signs resembling vascular acrosyndromes during the COVID-19 outbreak in Italy, Clin. Exp. Dermatol., 45, 757, 10.1111/ced.14267

Paolino, 2020, Diffuse cutaneous manifestation in a new mother with COVID-19 (SARS-Cov-2), Int. J. Dermatol., 59, 874, 10.1111/ijd.14919

Diaz-Guimaraens, 2020, Petechial skin rash associated with severe acute respiratory syndrome coronavirus 2 infection, JAMA Dermatol., 156, 820, 10.1001/jamadermatol.2020.1741

Quintana-Castanedo, 2020, Urticarial exanthem as early diagnostic clue for COVID-19 infection, JAAD Case Rep., 6, 498, 10.1016/j.jdcr.2020.04.026

Fernandez-Nieto, 2020, Characterization of acute acral skin lesions in nonhospitalized patients: a case series of 132 patients during the COVID-19 outbreak, J. Am. Acad. Dermatol., 83, e61, 10.1016/j.jaad.2020.04.093

Bouaziz, 2020, Vascular skin symptoms in COVID-19: a French observational study, J. Eur. Acad. Dermatol. Venereol., 10.1111/jdv.16544

Piccolo, 2020, Chilblain-like lesions during COVID-19 epidemic: a preliminary study on 63 patients, J. Eur. Acad. Dermatol. Venereol., 34, e291, 10.1111/jdv.16526

Sanchez, 2020, Digitate papulosquamous eruption associated with severe acute respiratory syndrome coronavirus 2 infection, JAMA Dermatol., 156, 819, 10.1001/jamadermatol.2020.1704

Alramthan, 2020, Two cases of COVID-19 presenting with a clinical picture resembling chilblains: first report from the Middle East, Clin. Exp. Dermatol., 45, 746, 10.1111/ced.14243

Gianotti, 2020, Cutaneous clinico-pathological findings in three COVID-19-positive patients observed in the metropolitan area of milan, Italy, Acta Derm. Venereol., 100, 10.2340/00015555-3490

Matar, 2020, Cutaneous manifestations in SARS-CoV-2 infection (COVID-19): a French experience and a systematic review of the literature, J. Eur. Acad. Dermatol. Venereol., 10.1111/jdv.16775

Askin, 2020, Cutaneous manifestations in hospitalized patients diagnosed as COVID-19, Dermatol. Ther., 10.1111/dth.13896

Annunziata, 2020, Cutaneous involvement during COVID-19 pandemic: an emerging sign of infection, J. Eur. Acad. Dermatol. Venereol., 10.1111/jdv.16769

Najafzadeh, 2020, Urticaria (angioedema) and COVID-19 infection, J. Eur. Acad. Dermatol. Venereol., 10.1111/jdv.16721

Gaspari, 2020, COVID-19: how it can look on the skin. Clinical and pathological features in 20 COVID-19 patients observed in Bologna, north-eastern Italy, J. Eur. Acad. Dermatol. Venereol., 10.1111/jdv.16693

Calvão, 2020, Acro-ischaemia and COVID-19 infection: clinical and histopathological features, J. Eur. Acad. Dermatol. Venereol., 10.1111/jdv.16687

El Hachem, 2020, A clinical, histopathological and laboratory study of 19 consecutive Italian paediatric patients with chilblain-like lesions: lights and shadows on the relationship with COVID-19 infection, J. Eur. Acad. Dermatol. Venereol., 10.1111/jdv.16682

Saenz Aguirre, 2020, Novel outbreak of acral lesions in times of COVID-19: a description of 74 cases from a tertiary university hospital in Spain, Clin. Exp. Dermatol., 10.1111/ced.14294

Rodríguez-Jiménez, 2020, Urticaria-like lesions in COVID-19 patients are not really urticaria - a case with clinicopathological correlation, J. Eur. Acad. Dermatol. Venereol., 10.1111/jdv.16618

van Damme, 2020, Acute urticaria with pyrexia as the first manifestations of a COVID-19 infection, J. Eur. Acad. Dermatol. Venereol., 34, e300, 10.1111/jdv.16523

Ciccarese, 2020, Oral erosions and petechiae during SARS-CoV-2 infection, J. Med. Virol.

Bitar, 2020, Cutaneous manifestations of hospitalized coronavirus disease 2019 patients: a report of six cases with clinicopathologic features and viral RNA in situ hybridization, J. Eur. Acad. Dermatol. Venereol., 10.1111/jdv.16741

Kanitakis, 2020, Chilblain-like acral lesions during the COVID-19 pandemic ("COVID toes"): histologic, immunofluorescence, and immunohistochemical study of 17 cases, J. Am. Acad. Dermatol., 83, 870, 10.1016/j.jaad.2020.05.145

Conforti, 2020, “COVID-Mask”: an atypical livedoid manifestation of COVID-19 observed in a Northern Italy hospital, Dermatol. Ther., 33, 10.1111/dth.13701

Diotallevi, 2020, Skin involvement in SARS-CoV-2 infection: case series, J. Med. Virol., 10.1002/jmv.26012

Llamas-Velasco, 2020, Thrombotic occlusive vasculopathy in a skin biopsy from a livedoid lesion of a patient with COVID-19, Br. J. Dermatol., 183, 591, 10.1111/bjd.19222

Andina, 2020, Chilblains in children in the setting of COVID-19 pandemic, Pediatr. Dermatol., 37, 406, 10.1111/pde.14215

Garcia-Lara, 2020, Chilblain-like lesions in pediatrics dermatological outpatients during the COVID-19 outbreak, Dermatol. Ther., 33, 10.1111/dth.13516

Landa, 2020, Chilblain-like lesions on feet and hands during the COVID-19 Pandemic, Int. J. Dermatol., 59, 739, 10.1111/ijd.14937

López-Robles, 2020, Chilblain-like lesions: a case series of 41 patients during the COVID-19 pandemic, Clin. Exp. Dermatol., 45, 891, 10.1111/ced.14275

Ludzik, 2020, Case Report: chilblains-like lesions (COVID-19 toes) during the pandemic - is there a diagnostic window? F1000Res, 9, 668

Rosés-Gibert, 2020, Acral lesions in a pediatric population during the COVID-19 pandemic: a case series of 36 patients from a single hospital in Spain, World J Pediatr, 1

Ayatollahi, 2020, Late-onset AGEP-like skin pustular eruption following COVID-19: a possible association, Dermatol. Ther., n/a

Rerknimitr, 2020, Skin manifestations in COVID-19: the tropics experience, J. Dermatol., 47, e444, 10.1111/1346-8138.15567

Nasiri, 2020, Urticarial vasculitis in a COVID-19 recovered patient, Int. J. Dermatol., 59, 1285, 10.1111/ijd.15112

Boix-Vilanova, 2020, Grover-like skin eruption: another cutaneous manifestation in a COVID-19 patient, Int. J. Dermatol., 59, 1290, 10.1111/ijd.15104

Daneshjou, 2020, Pernio-like eruption associated with COVID-19 in skin of color, JAAD Case Rep., 6, 892, 10.1016/j.jdcr.2020.07.009

Mohan, 2020, Chilblains in COVID-19 infection, Cureus, 12

Neri, 2020, Acral skin eruption observed during SARS-CoV-2 pandemic: possible keratolysis exfoliativa with red palms and soles, J. Eur. Acad. Dermatol. Venereol., 10.1111/jdv.16881

Pangti, 2020, Recognizable vascular skin manifestations of SARS-CoV-2 (COVID-19) infection are uncommon in patients with darker skin phototypes, Clin. Exp. Dermatol., 46, 180, 10.1111/ced.14421

Jamiolkowski, 2020, SARS-CoV-2 PCR testing of skin for COVID-19 diagnostics: a case report, Lancet, 396, 598, 10.1016/S0140-6736(20)31754-2

Tatu, 2020, Familial clustering of COVID-19 skin manifestations, Dermatol. Ther., n/a

Young, 2020, Large sacral/buttocks ulcerations in the setting of coagulopathy: a case series establishing the skin as a target organ of significant damage and potential morbidity in patients with severe COVID-19, Int. Wound J., 17, 2033, 10.1111/iwj.13457

Droesch, 2020, Livedoid and purpuric skin eruptions associated with coagulopathy in severe COVID-19, JAMA Dermatol., 156, 1, 10.1001/jamadermatol.2020.2800

Jimenez-Cauhe, 2020, Enanthem in patients with COVID-19 and skin rash, JAMA Dermatol., 156, 1134, 10.1001/jamadermatol.2020.2550

Suter, 2020, Erythema nodosum as a cutaneous manifestation of COVID-19 infection, BMJ Case Rep., 13, 10.1136/bcr-2020-236613

Shanshal, 2020, COVID-19 related anagen effluvium, J. Dermatol. Treat., 1

Potekaev, 2020, Clinical characteristics of dermatologic manifestations of COVID-19 infection: case series of 15 patients, review of literature, and proposed etiological classification, Int. J. Dermatol., 59, 1000, 10.1111/ijd.15030

Micevic, 2020, Pernio-like lesions and coagulopathy in a patient with COVID-19 infection, JAAD Case Rep., 10.1016/j.jdcr.2020.08.042

Fida, 2020, Case report: SARS-CoV-2-induced urticaria or just a concomitance?, Dermatol. Ther., 10.1111/dth.14250

Motohashi, 2020, Development of maculopapular exanthem in a COVID-19 patient, J. Dermatol., 47, e426, 10.1111/1346-8138.15579

Abasaeed Elhag, 2020, Angioedema and urticaria in a COVID-19 patient: a case report and review of the literature, JAAD Case Rep., 6, 1091, 10.1016/j.jdcr.2020.07.042

Khalil, 2020, Livedo reticularis as a presenting sign of severe acute respiratory syndrome coronavirus 2 infection, JAAD Case Rep., 6, 871, 10.1016/j.jdcr.2020.07.014

Sipfle Do, 2020, Erythema nodosum-like rash in a COVID-19 patient: a case report, Am. J. Emerg. Med., S0735–6757

Stavert, 2020, Evaluation of SARS-CoV-2 antibodies in 24 patients presenting with chilblains-like lesions during the COVID-19 pandemic, J. Am. Acad. Dermatol., S0190–9622, 32440

García-Gil, 2020, Acro-ischemic lesions associated with extremely elevated D-Dimer in a child during the COVID-19 pandemic, Australas. J. Dermatol., 10.1111/ajd.13424

Gananandan, 2020, Guttate psoriasis secondary to COVID-19, BMJ Case Rep., 13, 10.1136/bcr-2020-237367

Mizutani, 2020, Late-onset cutaneous manifestations in a patient with severe COVID-19 infection, J. Dermatol., 47, e347, 10.1111/1346-8138.15520

Proietti, 2020, Auricle perniosis as a manifestation of Covid-19 infection, Dermatol. Ther., n/a

Aghazadeh, 2020, Oral vesicles and acral erythema: report of a cutaneous manifestation of COVID-19, Int. J. Dermatol., 59, 1153, 10.1111/ijd.15047

Tammaro, 2020, Necrotic acral lesions and lung failure in a fatal case of COVID-19, Australas. J. Dermatol., 10.1111/ajd.13400

Hassan, 2020, Urticaria and angioedema as a prodromal cutaneous manifestation of SARS-CoV-2 (COVID-19) infection, BMJ Case Rep., 13, 10.1136/bcr-2020-236981

Quintana-Castanedo, 2020, Concurrent chilblains and retinal vasculitis in a child with COVID-19, J. Eur. Acad. Dermatol. Venereol., 10.1111/jdv.16801

Dominguez-Santas, 2020, Minor aphthae associated with SARS-CoV-2 infection, Int. J. Dermatol., 59, 1022, 10.1111/ijd.15004

Freeman, 2020, The spectrum of COVID-19-associated dermatologic manifestations: an international registry of 716 patients from 31 countries, J. Am. Acad. Dermatol., 83, 1118, 10.1016/j.jaad.2020.06.1016

Farouk, 2020, Cutaneous manifestations of COVID-19: a case report and a new finding from Egypt, Dermatol. Ther., 10.1111/dth.14038

Beaupre, 2020, Mixed purpuric and maculopapular lesions in a patient with COVID-19: a case report, Clin Pract Cases Emerg Med, 4, 349, 10.5811/cpcem.2020.6.48617

Ahouach, 2020, Cutaneous lesions in a patient with COVID-19: are they related?, Br. J. Dermatol., 183, 10.1111/bjd.19168

Rizzoli, 2020, Chilblain-like lesions during the COVID-19 pandemic: a serological study on a case series, Br. J. Dermatol., 183, 782, 10.1111/bjd.19348

Méndez Maestro, 2020, Skin manifestations in patients hospitalized with confirmed COVID-19 disease: a cross-sectional study in a tertiary hospital, Int. J. Dermatol., 59, 1353, 10.1111/ijd.15180

Karagounis, 2020, Acrofacial purpura and necrotic ulcerations in COVID-19: a case series from New York City, Int. J. Dermatol., 59, 1419, 10.1111/ijd.15181

Nuno-Gonzalez, 2020, Prevalence of mucocutaneous manifestations, oral and palmoplantar findings in 666 patients with COVID-19 in a field hospital in Spain, Br. J. Dermatol.

Gallizzi, 2020, Management of pernio-like cutaneous manifestations in children during the outbreak of COVID-19, Dermatol. Ther., n/a

Sedaghat, 2020, Guillain Barre syndrome associated with COVID-19 infection: a case report, J. Clin. Neurosci., 76, 233, 10.1016/j.jocn.2020.04.062

Hutchins, 2020, COVID-19–Associated Bifacial weakness with paresthesia subtype of guillain-Barré syndrome, Am. J. Neuroradiol., 41, 1707

Romero-Sánchez, 2020, Neurologic manifestations in hospitalized patients with COVID-19, The ALBACOVID Reg., 95

Padroni, 2020, Guillain-Barré syndrome following COVID-19: new infection, old complication?, J. Neurol., 267, 1877, 10.1007/s00415-020-09849-6

Camdessanche, 2020, COVID-19 may induce Guillain-Barré syndrome, Rev. Neurol. (Paris), 176, 516, 10.1016/j.neurol.2020.04.003

Farzi, 2020, Guillain-Barré syndrome in a patient infected with SARS-CoV-2, a case report, J. Neuroimmunol., 346, 10.1016/j.jneuroim.2020.577294

Oguz-Akarsu, 2020, Guillain-barré syndrome in a patient with minimal symptoms of COVID-19 infection, Muscle Nerve, 62, E54

Alberti, 2020, Guillain-Barré syndrome related to COVID-19 infection, Neurol Neuroimmunol Neuroinflamm, 7, e741, 10.1212/NXI.0000000000000741

Lantos, 2020, COVID-19–Associated miller Fisher syndrome: MRI findings, Am. J. Neuroradiol., 41, 1184, 10.3174/ajnr.A6609

Ottaviani, 2020, Early Guillain-Barré syndrome in coronavirus disease 2019 (COVID-19): a case report from an Italian COVID-hospital, Neurol. Sci., 41, 1351, 10.1007/s10072-020-04449-8

Rana, 2020, Novel coronavirus (COVID-19)-Associated guillain-Barré syndrome: case report, J. Clin. Neuromuscul. Dis., 21, 240, 10.1097/CND.0000000000000309

Assini, 2020, New clinical manifestation of COVID-19 related Guillain-Barrè syndrome highly responsive to intravenous immunoglobulins: two Italian cases, Neurol. Sci., 41, 1657, 10.1007/s10072-020-04484-5

Scheidl, 2020, Guillain-Barré syndrome during SARS-CoV-2 pandemic: a case report and review of recent literature, J. Peripher. Nerv. Syst., 25, 204, 10.1111/jns.12382

Reyes-Bueno, 2020, Miller-Fisher syndrome after SARS-CoV-2 infection, Eur. J. Neurol., 10.1111/ene.14383

Sancho-Saldaña, 2020, Guillain-Barré syndrome associated with leptomeningeal enhancement following SARS-CoV-2 infection, Clin. Med., 20, e93, 10.7861/clinmed.2020-0213

Marta-Enguita, 2020, Fatal Guillain-Barre syndrome after infection with SARS-CoV-2, Neurologia, 35, 265, 10.1016/j.nrl.2020.04.004

Kilinc, 2020, Guillain-Barré syndrome after SARS-CoV-2 infection, Eur. J. Neurol., 10.1111/ene.14398

Arnaud, 2020, Post SARS-CoV-2 guillain-Barré syndrome, Clin. Neurophysiol., 131, 1652, 10.1016/j.clinph.2020.05.003

Bigaut, 2020, Guillain-Barré syndrome related to SARS-CoV-2 infection, Neurol Neuroimmunol Neuroinflamm, 7, e785, 10.1212/NXI.0000000000000785

Su, 2020, SARS-CoV-2-associated Guillain-Barré syndrome with dysautonomia, Muscle Nerve, 62, E48, 10.1002/mus.26988

Toscano, 2020, Guillain-barré syndrome associated with SARS-CoV-2, N. Engl. J. Med., 382, 2574, 10.1056/NEJMc2009191

Lascano, 2020, SARS-CoV-2 and Guillain-Barré syndrome: AIDP variant with favorable outcome, Eur. J. Neurol., 10.1111/ene.14368

Helbok, 2020, Guillain-Barré syndrome in a patient with antibodies against SARS-COV-2, Eur. J. Neurol., 10.1111/ene.14388

Coen, 2020, Guillain-Barré syndrome as a complication of SARS-CoV-2 infection, Brain Behav. Immun., 87, 111, 10.1016/j.bbi.2020.04.074

Chan, 2020, Guillain-barré syndrome with facial diplegia related to SARS-CoV-2 infection, Can. J. Neurol. Sci., 1, 10.1017/cjn.2020.256

Riva, 2020, Post-infectious Guillain-Barré syndrome related to SARS-CoV-2 infection: a case report, J. Neurol., 267, 2492, 10.1007/s00415-020-09907-z

Zhao, 2020, Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence?, Lancet Neurol., 19, 383, 10.1016/S1474-4422(20)30109-5

Juliao Caamaño, 2020, Facial diplegia, a possible atypical variant of Guillain-Barré Syndrome as a rare neurological complication of SARS-CoV-2, J. Clin. Neurosci., 77, 230, 10.1016/j.jocn.2020.05.016

Virani, 2020, Guillain-Barré Syndrome associated with SARS-CoV-2 infection, IDCases, 20, 10.1016/j.idcr.2020.e00771

Webb, 2020, Guillain-Barré syndrome following COVID-19: a newly emerging post-infectious complication, BMJ Case Rep., 13, 10.1136/bcr-2020-236182

Novi, 2020, Acute disseminated encephalomyelitis after SARS-CoV-2 infection, Neurol Neuroimmunol Neuroinflamm, 7, e797, 10.1212/NXI.0000000000000797

Reichard, 2020, Neuropathology of COVID-19: a spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology, Acta Neuropathol., 140, 1, 10.1007/s00401-020-02166-2

Bracaglia, 2020, Acute inflammatory demyelinating polyneuritis in association with an asymptomatic infection by SARS-CoV-2, J. Neurol., 1

Domingues, 2020, First case of SARS-COV-2 sequencing in cerebrospinal fluid of a patient with suspected demyelinating disease, J. Neurol., 1

Parsons, 2020, COVID-19-associated acute disseminated encephalomyelitis (ADEM), J. Neurol., 1

Dixon, 2020, COVID-19-related acute necrotizing encephalopathy with brain stem involvement in a patient with aplastic anemia, Neurol Neuroimmunol Neuroinflamm, 7, e789, 10.1212/NXI.0000000000000789

Brun, 2020, COVID-19-White matter and globus pallidum lesions: demyelination or small-vessel vasculitis?, Neurol Neuroimmunol Neuroinflamm, 7, e777, 10.1212/NXI.0000000000000777

Zanin, 2020, SARS-CoV-2 can induce brain and spine demyelinating lesions, Acta Neurochir., 162, 1491, 10.1007/s00701-020-04374-x

El Otmani, 2020, Covid-19 and guillain-Barré syndrome: more than a coincidence!, Rev. Neurol. (Paris), 176, 518, 10.1016/j.neurol.2020.04.007

Paterson, 2020, The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings, Brain, 143, 3104, 10.1093/brain/awaa240

Paybast, 2020, Guillain-barré syndrome as a neurological complication of novel COVID-19 infection: a case report and review of the literature, Neurol., 25, 101

Maideniuc, 2020, Acute necrotizing myelitis and acute motor axonal neuropathy in a COVID-19 patient, J. Neurol., 1

Zito, 2020, COVID-19 and guillain-Barré syndrome: a case report and review of literature, Front. Neurol., 11, 10.3389/fneur.2020.00909

Agosti, 2020, Is Guillain-Barrè syndrome triggered by SARS-CoV-2? Case report and literature review, Neurol. Sci., 1

Ameer, 2020, Guillain-Barré syndrome presenting with COVID-19 infection, BMJ Case Rep., 13, 10.1136/bcr-2020-236978

Diez-Porras, 2020, Guillain-Barré-Strohl syndrome and COVID-19: case report and literature review, Neuromuscul. Disord., 30, 859, 10.1016/j.nmd.2020.08.354

García-Manzanedo, 2020, Guillain-Barré syndrome after covid-19 infection, Med. Clin., 155, 10.1016/j.medcli.2020.06.023

Manganotti, 2020, Clinical neurophysiology and cerebrospinal liquor analysis to detect Guillain-Barré syndrome and polyneuritis cranialis in COVID-19 patients: a case series, J. Med. Virol.

Abrams, 2020, Severe rapidly progressive Guillain-Barré syndrome in the setting of acute COVID-19 disease, J. Neurovirol., 26, 797, 10.1007/s13365-020-00884-7

Tiet, 2020, Guillain-Barré syndrome associated with COVID-19 infection: a case from the UK, BMJ Case Rep., 13, 10.1136/bcr-2020-236536

Ray, 2020, Miller Fisher syndrome and COVID-19: is there a link?, BMJ Case Rep., 13, 10.1136/bcr-2020-236419

Liberatore, 2020, Clinical Reasoning: a case of COVID-19 associated pharyngeal-cervical-brachial variant of Guillain-Barré syndrome, Neurology, 10.1212/WNL.0000000000010817

Khalifa, 2020, Guillain-barré syndrome associated with severe acute respiratory syndrome coronavirus 2 detection and coronavirus disease 2019 in a child, J Pediatric Infect Dis Soc, 9, 510, 10.1093/jpids/piaa086

Frank, 2020, Guillain-barré syndrome associated with SARS-CoV-2 infection in a pediatric patient, J. Trop. Pediatr., 10.1093/tropej/fmaa044

Kopscik, 2020, A case report of acute motor and sensory polyneuropathy as the presenting symptom of SARS-CoV-2, Clin Pract Cases Emerg Med, 4, 352, 10.5811/cpcem.2020.6.48683

Elkhouly, 2020, Noteworthy neurological manifestations associated with COVID-19 infection, Cureus, 12

Masuccio, 2020, A rare case of acute motor axonal neuropathy and myelitis related to SARS-CoV-2 infection, J. Neurol., 1

Senel, 2020, Miller-Fisher syndrome after COVID-19: neurochemical markers as an early sign of nervous system involvement, Eur. J. Neurol., 27, 2378, 10.1111/ene.14473

Foresti, 2020, COVID-19 provoking Guillain–Barré syndrome: the Bergamo case series, Eur. J. Neurol., 10.1111/ene.14549

Durrani, 2020, Acute transverse myelitis secondary to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): a case report, Clin Pract Cases Emerg Med, 4, 344, 10.5811/cpcem.2020.6.48462

Pelea, 2020, SARS-CoV-2 associated Guillain-Barré syndrome, J. Neurol., 1

Granger, 2020, SARS-CoV-2–Associated guillain–Barre syndrome with good response to plasmapheresis, J. Clin. Neuromuscul. Dis., 22, 10.1097/CND.0000000000000310

Civardi, 2020, Antiganglioside antibodies in Guillain-Barré syndrome associated with SARS-CoV-2 infection, J. Neurol. Neurosurg. Psychiatr., 91, 1361, 10.1136/jnnp-2020-324279

Wada, 2020, Neurological disorders identified during treatment of a SARS-CoV-2 infection, Intern. Med., 59, 2187, 10.2169/internalmedicine.5447-20

Naddaf, 2020, Guillain-barré syndrome in a patient with evidence of recent SARS-CoV-2 infection, Mayo Clin. Proc., 95, 1799, 10.1016/j.mayocp.2020.05.029

Gutiérrez-Ortiz, 2020, Miller Fisher syndrome and polyneuritis cranialis in COVID-19, Neurology, 95, 10.1212/WNL.0000000000009619

Chow, 2020, Acute transverse myelitis in COVID-19 infection, BMJ Case Rep., 13, 10.1136/bcr-2020-236720

Sotoca, 2020, COVID-19-associated acute necrotizing myelitis, Neurol Neuroimmunol Neuroinflamm, 7, 10.1212/NXI.0000000000000803

Chakraborty, 2020, COVID-19-associated acute transverse myelitis: a rare entity, BMJ Case Rep., 13, 10.1136/bcr-2020-238668

Fernández-Domínguez, 2020, Miller-Fisher-like syndrome related to SARS-CoV-2 infection (COVID 19), J. Neurol., 267, 2495, 10.1007/s00415-020-09912-2

Manganotti, 2020, Miller Fisher syndrome diagnosis and treatment in a patient with SARS-CoV-2, J. Neurovirol., 26, 605, 10.1007/s13365-020-00858-9

Korem, 2020, Guillain-Barré syndrome associated with COVID-19 disease, BMJ Case Rep., 13, 10.1136/bcr-2020-237215

Thông tin
Thông tin xuất bản

Journal of Autoimmunity

Tập 117

102592

Thông tin tác giả